NCT05114486View on ClinicalTrials.gov

Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

September 20, 2022

Study Completion Date

September 20, 2022

Conditions
Presbyopia
Interventions
COMBINATION_PRODUCT

Pilocarpine Ophthalmic administered with the Optejet dispenser

Pilocarpine 2% ophthalmic spray administered with the Optejet dispenser

COMBINATION_PRODUCT

Placebo administered with the Optejet dispenser

Vehicle ophthalmic solution administered with the Optejet dispenser

Trial Locations (9)

19141

VISION-2 Study Site #58, Philadelphia

38119

VISION-2 Study Site #55, Memphis

40206

VISION-2 Study Site #56, Louisville

43210

VISION-2 Study Site #19, Columbus

57018

VISION-2 Study Site #62, Sioux Falls

78731

VISON-2 Study Site #60, Austin

84020

VISION-2 Study Site #61, Draper

92131

VISION-2 Study Site #57, San Diego

06890

VISION-2 Study Site #59, Fairfield

Sponsors

Lead Sponsor

Eyenovia Inc.
All Listed Sponsors
lead

Eyenovia Inc.

INDUSTRY